Articles

Web site developer Imavex gets new CEO

A former executive of Indianapolis-based engineering firm The Schneider Corp. has been named CEO of Imavex LLC, a Noblesville-based
Web site developer and Internet marketing consultant.

Read More

BlueLock plans $35.6 million investment, 118 new jobs

Indianapolis-based tech firm BlueLock LLC is poised to continue its growth spurt, planning a $35.6 million investment at its
north-side facility that could create 118 jobs. City planners have recommended approval of a 10-year tax abatement.

Read More

Simon, rival seek foreign investors to back General Growth bid

Indianapolis-based Simon Property Group and its chief rival in the battle to acquire bankrupt shopping mall operator General
Growth Properties Inc. are seeking funding from sovereign wealth funds in the Middle East and Asia, according to the Financial
Times
of London.

Read More

Carmel contractor offers scholarships

Carmel-based Williams Comfort Air, a heating and cooling contractor, is accepting nominations for its Extraordinairy Treasures annual scholarship program. Six one-time scholarships totaling $5,000 will be awarded to high school seniors based on community service, leadership activities and family commitment.

Read More

Minority networking event set for April 25

“Staying Alive and Productive during Economic Hard Times” is the theme of the Indianapolis Professional Association’s seventh
annual networking luncheon. It will include a roundtable discussion of the economic state of local minority businesses and
organizations.

Read More

EDITORIAL: Citizens’ utility deal is smart move

Much work remains before the city’s water and sewer utilities are sold to Citizens Energy Group, but the general outline
of the deal makes sense and deserves support—not political posturing—as final terms are hammered out.

Read More

Records

Public records listing from the March 15, 2010, edition of IBJ.

Read More

HEALTH CARE

With President Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper. Lilly is already trying to shave a year or more off the time it takes the company’s scientists to turn a newly […]

Read More